W. Faber

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Y. Amoako, P. Saunderson, F. Sarfo, 2020, The Lancet.

SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics

J. Carcillo, S. Rajasekaran, Xiaopeng Li, 2020, The Journal of Biological Chemistry.

SARS-CoV2 (COVID-19) Structural/Evolution Dynamicome: Insights into functional evolution and human genomics

J. Carcillo, S. Rajasekaran, B. Uhal, 2020, bioRxiv.

High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals

J. Carcillo, D. Chesla, S. Rajasekaran, 2021, Frontiers in Immunology.

Pain, Pain, Go Away

W. Faber, M. Walker, 2009 .

SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics

S. Rajasekaran, J. Prokop, N. Hartog, 2021, Expert review of proteomics.